Delivery Order SPE2DB22D1106-SPE2DB25FEKD7

Award Date 4/23/25
Potential Completion Date 4/24/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,837.76 for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,003.51, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS. This is a firm-fixed-price delivery order contract with a period of performance through March 12, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,001.17 firm fixed-price delivery order is for VIVITROL 380 MG VIAL-DILUENTS and has a completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in...
This federal contract award, valued at $2,002.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a critical pharmaceutical product. The contract has an ultimate completion date of January 14, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,002.34, is a delivery order for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and the contract is...
This federal contract award, valued at $18,999.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a critical medical product, to support military healthcare programs. This is a firm-fixed-price delivery order contract with a period of performance through February 4, 2025. The contract was awarded without a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,002.34, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is April 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The $8,991.22 fixed-price delivery order was awarded on December 13, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through December 16, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is for the delivery of VIVITROL 380 MG VIAL-DILUENTS medical supplies. The contract, valued at $12,296.96, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical under Delivery Order SPE2DX15D1053|SPE2DX25F6FQB. This is a firm fixed-price contract with a completion date of January 2, 2025. The contract is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,648.35 firm fixed-price delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of alcohol and opioid dependence. The contract has an ultimate completion date of May 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEKD7
    Delivery Order

This federal contract award, valued at $3,003.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of April 24, 2025.

Amerisourcebergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

The contract award is not designated as a set-aside, indicating open competition.

Generated 7/23/25, 9:55 AM